Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts.

Article Details

Citation
Copy to clipboard

Lallemand F, Schmitt M, Bourges JL, Gurny R, Benita S, Garrigue JS

Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts.

Eur J Pharm Biopharm. 2017 Aug;117:14-28. doi: 10.1016/j.ejpb.2017.03.006. Epub 2017 Mar 14.

PubMed ID
28315447 [ View in PubMed
]
Abstract

Local ocular delivery of cyclosporine A (CsA) is the preferred method for CsA delivery as a treatment for ocular inflammatory diseases such as uveitis, corneal healing, vernal keratoconjunctivitis and dry eye disease. However, due to the large molecular weight and hydrophobic nature of CsA and the natural protective mechanisms of the eye, achieving therapeutic levels of CsA in ocular tissues can be difficult. This review gives a comprehensive overview of the current products available to clinicians as well as emerging drug delivery solutions that have been developed at both the academic and industry levels.

DrugBank Data that Cites this Article

Drugs